Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

Neuroendocrine Cancer COVID Survey

Neuroendocrine Cancer COVID Survey

Share your experience and make it count in this Neuroendocrine Cancer Covid survey! The NET Connect survey remains open for a few more days – until August 31st. #LetsTalkAboutNETs   ➡️ https://survey.eu.qualtrics.com/jfe/form/SV_bQudNmSOhtorTEO  

read more
Neuroendocrine Cancer – Research & Clinical Trials

Neuroendocrine Cancer – Research & Clinical Trials

  During August, we're posting videos from our Patient Education Event. Today's is by Martyn Caplin, Prof of Gastroenterology & GI Neuroendocrinology at The Royal Free London: Research & Clinical Trials Watch video here ➡️ https://vimeo.com/476058211

read more